ArticleNagoya journal of medical science2026
A polymorphism in the
Article in Nagoya journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with hypertension are recommended to decrease their salt intake. However, some patients do not follow this recommendation. It is possible that some of these individuals cannot restrict their salt intake due to a genetic preference for salt. Thus, we attempted to identify genetic factors related to salt restriction behavior. The subjects were 817 patients with hypertension. Salt restriction status was determined by self-reported answers (yes/no) to the question "Do you restrict your salt intake in everyday meals?" We focused on 21 single-nucleotide polymorphisms related to genes involved in the regulation of blood pressure, salt metabolism, or neurotransmission, and analyzed the associations of the single-nucleotide polymorphisms with salt restriction behavior. Of the 817 subjects, 568 (69.5%) reported that they restricted their salt intake. Two single-nucleotide polymorphisms (rs1167998 and rs2970847) were found to be correlated with salt restriction behavior. Among the 21 single-nucleotide polymorphisms, rs1167998 in the intron region of the dedicator of cytokinesis 7 gene, which encodes a guanine nucleotide exchange factor that plays a role in axon formation and neuronal polarization, showed the strongest association (odds ratio per allele, 1.48; 95% confidence interval, 1.11 to 1.95). In conclusion, rs1167998, a single-nucleotide polymorphism in the dedicator of cytokinesis 7 gene that is associated with blood lipid levels and cardiovascular disease risk was associated with salt restriction behavior in a population of Japanese patients with hypertension. Further confirmatory studies are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.